HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

tocilizumab (atlizumab)

a humanised anti-interleukin-6 receptor monoclonal antibody
Also Known As:
atlizumab; Actemra; BAT-1806; BAT1806; MSB-11456; MSB11456; R-1569; RG-1569; RHPM-1; RO-4877533; Roactemra; monoclonal antibody, MRA
Networked: 3822 relevant articles (712 outcomes, 789 trials/studies)

Relationship Network

Drug Context: Research Results

Experts

1. Takeuchi, Tsutomu: 43 articles (10/2022 - 09/2007)
2. Kishimoto, Tadamitsu: 38 articles (01/2022 - 03/2005)
3. Nishimoto, Norihiro: 38 articles (01/2020 - 03/2005)
4. Tanaka, Toshio: 31 articles (01/2021 - 12/2009)
5. Salvarani, Carlo: 29 articles (11/2022 - 10/2011)
6. Kaneko, Yuko: 27 articles (10/2022 - 10/2011)
7. Kawakami, Atsushi: 25 articles (04/2022 - 02/2010)
8. Tanaka, Yoshiya: 25 articles (01/2021 - 04/2011)
9. Yokota, Shumpei: 24 articles (01/2020 - 03/2005)
10. Ogata, Atsushi: 23 articles (09/2019 - 12/2009)

Related Diseases

1. COVID-19
2. Rheumatoid Arthritis
3. Inflammation (Inflammations)
4. Juvenile Arthritis (Juvenile Idiopathic Arthritis)
5. Pneumonia (Pneumonitis)

Related Drugs and Biologics

1. Interleukin-6 (Interleukin 6)
2. Interleukin-6 Receptors (Interleukin 6 Receptor)
3. Monoclonal Antibodies
4. Methotrexate (Mexate)
5. Rituximab (Mabthera)
6. Glucocorticoids
7. Adrenal Cortex Hormones (Corticosteroids)
8. Abatacept (Orencia)
9. Steroids
10. Interleukin 1 Receptor Antagonist Protein (Anakinra)

Related Therapies and Procedures

1. Therapeutics
2. Artificial Respiration (Mechanical Ventilation)
3. Aftercare (After-Treatment)
4. Drug Therapy (Chemotherapy)
5. Immunomodulation